News
Neues vom BioCity Campus

Hybrid Conference: Energy Saxony Summit 2021 on December 9 in Dresden

2021 is the year when the need for decarbonisation becomes tangible for everyone. Everything is now being put to the climate test – in every branch of industry. The potential of an optimised circular economy must also contribute to securing raw materials and reducing emissions so that the transition to a clean,CO2-neutraland circular economy can succeed by 2050. Both topics are the focus of the 7. ENERGY SAXONY SUMMIT on 9 December 2021 at Messe Dresden.

  • In the keynote session, background information on the European Green Deal as well as insights into the Saxon energy and climate program will be given. In addition, best practice examples from the region show the opportunities of the upcoming transformation.
  • In the subsequent innovation forums on the topic of decarbonisation and the circular economy as well as in the accompanying virtual permanent exhibition and in the context of exhibitor pitches on the WEFRAME Board, research stakeholders as well as technology and service providers will have the opportunity to present their solutions for shaping change.
  • Sufficient time for networking and content discussion are offered by the offer of a business breakfast in the morning as a warm-up, a coffee break in the afternoon and a networking dinner after the lecture program

 

Source: Event area www.energy-saxony.net


Previous News

BIO-Europe 2022 will be held in Leipzig, October 24 – 26

“We are more than honoured to host BIO-Europe 2022 in Leipzig” said André Hofmann, CEO of biosaxony Management GmbH. “The biosaxony Cluster has made impressive progress since BIO-Europe’s last stop over here – it’s definitely worth a visit!”

Next News

OFB Projektentwicklung realises biotechnology campus in Leipzig and thus creates new headquarters for c-LEcta

OFB is developing a biotechnology campus in Leipzig by the fourth quarter of 2024. The first section with around 10,425 m² of above-ground lettable space has already been fully let to the biotechnology company c-LEcta.